Skip to main content

Advertisement

Log in

Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the efficacy and safety of 2 micron continuous wave laser resection of non-muscle-invasive bladder tumor (NMIBT) compared with holmium laser resection of bladder tumor (HoLRBT) and standard transurethral resection of bladder tumor (TURBT).

Methods

Since April 2006 to August 2007, 97 patients with NMIBT were retrospectively collected in this study. All of them were classified into 3 groups, which were treated with 2 micron continuous wave laser resection, holmium laser resection and TURBT, respectively. The preoperative, intraoperative and postoperative clinical data were recorded and compared using SAS 6.12 statistical software.

Results

There were no differences with the preoperative characteristics among the three groups, except the diameter of the tumors. The maximum diameter of the tumors in 2 micron laser group was larger than the other two groups (P < 0.05). Two micron laser group was associated with less hemoglobin decrease compared with TURBT group (P < 0.05). All of the patients were followed and the recurrence rate of the three groups indicated no statistical significance (P > 0.05).

Conclusions

In conclusion, 2 micron continuous wave laser resection of non-muscle-invasive bladder tumor is a safe and reliable treatment. With the distinguished hemostasis, it is an available optional treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Madeb R, Messing EM (2004) Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 22(2):86–92

    PubMed  Google Scholar 

  2. Underwood W 3rd, Dunn RL, Williams C et al (2006) Gender and geographic influence on the racial disparity in bladder cancer mortality in the US. J Am Coll Surg 202(2):284–290

    Article  PubMed  Google Scholar 

  3. No authors listed (2009) StatBite: A look at bladder cancer in the United States. J Natl Cancer Inst 101(22):1533

    Article  Google Scholar 

  4. Shi B, Zhang K, Zhang J et al (2008) Relationship between patient age and superficial transitional cell carcinoma characteristics. Urology 71(6):1186–1190

    Article  PubMed  Google Scholar 

  5. Pietrow PK, Smith JJ (2001) Laser treatment for invasive and noninvasive carcinoma of the bladder. J Endourol 15(4):415–418

    Article  CAS  PubMed  Google Scholar 

  6. Devos D, Creac’h C, Laureau E et al (2000) Thulium laser evoked potentials. Normative values for the arms and legs. Neurophysiol Clin 30(5):313–322

    Article  CAS  PubMed  Google Scholar 

  7. Fried NM, Murray KE (2005) High-Power thulium fiber laser ablation of urinary tissues at 1.94um. J Endourol 19(1):25–31

    Article  PubMed  Google Scholar 

  8. Xia SJ, Zhuo J, Sun XW et al (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389

    Article  PubMed  Google Scholar 

  9. Xia SJ, Zhang YN, Lu J et al (2005) Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia. Zhonghua Yi Xue Za Zhi 85(45):3225–3228

    PubMed  Google Scholar 

  10. Gao X, Ren S, Xu C et al (2008) Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience. BJU Int 102(9):1115–1118

    Article  PubMed  Google Scholar 

  11. Yang Y, Hong BF, Wei ZT (2008) Continuous wave laser of 2 microm for bladder tumor treatment. Zhonghua Wai Ke Za Zhi 46(18):1410–1412

    PubMed  Google Scholar 

  12. Okamura K, Ono Y, Kinukawa T et al (2002) Randomized study of single early instillation of (2”R)-4’-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma. Cancer 94(9):2363–2368

    Article  CAS  PubMed  Google Scholar 

  13. Böhle A, Leyh H, Frei C et al (2009) Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study. Eur Urol 56(3):495–503

    Article  PubMed  Google Scholar 

  14. Syed HA, Biyani CS, Bryan N et al (2001) Holmium:YAG laser treatment of recurrent superficial bladder carcinoma: initial clinical experience. J Endourol 15(6):625–627

    Article  CAS  PubMed  Google Scholar 

  15. Xishuang S, Deyong Y, Xiangyu C et al (2010) Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol 24(1):69–73

    Article  PubMed  Google Scholar 

  16. Zhu Y, Jiang X, Zhang J et al (2008) Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience. Urology 72(3):608–612

    Article  PubMed  Google Scholar 

  17. Saito S (2001) Transurethral en bloc resection of bladder tumors. J Urol 166(6):2148–2150

    Article  CAS  PubMed  Google Scholar 

  18. Marks AJ, Teichman JM (2007) Lasers in clinical urology: state of the art and new horizons. World J Urol 25(3):227–233

    Article  PubMed  Google Scholar 

  19. Smith JA (1989) Current concepts in laser treatment of bladder cancer [J]. Prog Clin Biol Res 303:463–469

    PubMed  Google Scholar 

Download references

Conflict of interest statement

There is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shujie Xia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhong, C., Guo, S., Tang, Y. et al. Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience. World J Urol 28, 157–161 (2010). https://doi.org/10.1007/s00345-010-0532-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-010-0532-8

Keywords

Navigation